The case for conducting a randomized clinical trial to assess the efficacy of a single dose of prophylactic HPV vaccines among adolescents.

Kreimer AR, Sherman ME, Sahasrabuddhe VV, Safaeian M
J Natl Cancer Inst. 2015 107 (3)

PMID: 25650316 · PMCID: PMC4326307 · DOI:10.1093/jnci/dju436

MeSH Terms (12)

Adolescent Cost-Benefit Analysis Dose-Response Relationship, Drug Female Humans Immunization Schedule Papillomavirus Infections Papillomavirus Vaccines Randomized Controlled Trials as Topic Research Design United States Uterine Cervical Neoplasms

Connections (1)

This publication is referenced by other Labnodes entities: